The impact of dose of the angiotensin-receptor blocker valsartan on the post-myocardial infarction ventricular remodeling: study protocol for a randomized controlled trial

The impact of dose of the angiotensin-receptor blocker valsartan on the post-myocardial infarction ventricular remodeling: study protocol for a randomized controlled trial

<p>Abstract</p> <p>Background</p> <p>Angiotensin-converting enzyme inhibitors and the angiotensin-receptor blocker valsartan ameliorate ventricular remodeling after myocardial infarction (MI). Based on previous clinical trials, a maximum clinical dose is recommended in...

Full description

Bibliographic Details
Main Authors: Cho Young-Rak, Kim Young-Dae, Park Tae-Ho, Park Kyungil, Park Jong-Sung, Baek Heekyung, Choi Sun-Young, Kim Kee-Sik, Hong Taek-Jong, Yang Tae-Hyun, Hwang Jin-Yong, Park Jong-Seon, Hur Seung-Ho, Lee Sang-Gon
Format: Article
Language:English
Published: BMC 2011-11-01
Series:Trials
Subjects:
Valsartan
Myocardial Infarction
Online Access:http://www.trialsjournal.com/content/12/1/247

Similar Items

Similar Items